Skye Bioscience, Inc. Amortization of Debt Issuance Costs and Discounts
Skye Bioscience, Inc. (SKYE) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-03-10
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $0.00.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2024 was $599.01K, a 81.58% increase from fiscal 2023.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2023 was $329.89K, a 32.62% decline from fiscal 2022.
- Skye Bioscience, Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $489.60K, a 17.55% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-03-10 | $111.48K derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $111.48K derived: sum of 3 quarters · filed 2026-03-10 | $361.80K derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $111.48K derived: sum of 2 quarters · filed 2026-03-10 | $361.80K derived: sum of 3 quarters · filed 2026-03-10 | $599.01K 10-K · filed 2026-03-10 |
| 2024-09-30 | $111.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $361.80K derived: sum of 2 quarters · filed 2025-11-10 | $599.01K 10-Q · filed 2025-11-10 | $826.50K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $250.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $487.53K 10-Q · filed 2025-08-07 | $715.02K derived: sum of 3 quarters · filed 2025-08-07 | $817.42K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $237.21K 10-Q · filed 2025-05-08 | $464.69K derived: sum of 2 quarters · filed 2025-05-08 | $567.10K derived: sum of 3 quarters · filed 2025-05-08 | $567.10K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $227.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $329.89K derived: sum of 2 quarters · filed 2025-03-20 | $329.89K derived: sum of 3 quarters · filed 2025-03-20 | $329.89K 10-K · filed 2025-03-20 |
| 2023-09-30 | $102.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $102.40K derived: sum of 2 quarters · filed 2024-11-07 | $102.40K 10-Q · filed 2024-11-07 | $111.53K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $9.13K derived: sum of 3 quarters · filed 2024-08-09 | $174.67K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | $9.13K derived: sum of 2 quarters · filed 2024-05-10 | $174.67K derived: sum of 3 quarters · filed 2024-05-10 | $334.76K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $9.13K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $174.67K derived: sum of 2 quarters · filed 2024-03-22 | $334.76K derived: sum of 3 quarters · filed 2024-03-22 | $489.60K 10-K · filed 2024-03-22 |
| 2022-09-30 | $165.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $325.63K derived: sum of 2 quarters · filed 2023-11-14 | $480.47K 10-Q · filed 2023-11-14 | $635.22K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $160.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $314.93K 10-Q · filed 2023-08-07 | $469.67K derived: sum of 3 quarters · filed 2023-08-07 | $620.95K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $154.84K 10-Q · filed 2023-05-12 | $309.58K derived: sum of 2 quarters · filed 2023-05-12 | $460.86K derived: sum of 3 quarters · filed 2023-05-12 | $607.15K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $154.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $306.02K derived: sum of 2 quarters · filed 2023-03-31 | $452.31K derived: sum of 3 quarters · filed 2023-03-31 | $593.80K 10-K · filed 2023-03-31 |
| 2021-09-30 | $151.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $297.56K derived: sum of 2 quarters · filed 2022-11-14 | $439.05K 10-Q · filed 2022-11-14 | $580.46K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $146.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $287.78K 10-Q · filed 2022-08-15 | $429.19K derived: sum of 3 quarters · filed 2022-08-15 | $567.42K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $141.49K 10-Q · filed 2022-05-06 | $282.90K derived: sum of 2 quarters · filed 2022-05-06 | $421.13K derived: sum of 3 quarters · filed 2022-05-06 | $554.81K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $141.41K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $279.64K derived: sum of 2 quarters · filed 2022-03-28 | $413.32K derived: sum of 3 quarters · filed 2022-03-28 | $544.03K 10-K · filed 2022-03-28 |
| 2020-09-30 | $138.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $271.91K derived: sum of 2 quarters · filed 2021-11-10 | $402.62K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $133.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $264.39K 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | $130.71K 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |